{
    "id": "fc2f1626-a227-4aeb-8fed-ad4274a62915",
    "indications": {
        "text": "lamictal indicated : epilepsy\u2014adjunctive therapy patients aged 2 years older : \u2022 partial-onset seizures . \u2022 primary generalized tonic-clonic ( pgtc ) seizures . \u2022 generalized seizures lennox-gastaut syndrome . ( 1.1 ) epilepsy\u2014monotherapy patients aged 16 years older : conversion monotherapy patients partial-onset seizures receiving treatment carbamazepine , phenytoin , phenobarbital , primidone , valproate single antiepileptic . ( 1.1 ) bipolar disorder : maintenance treatment bipolar disorder delay time occurrence mood episodes patients treated acute mood episodes standard therapy . ( 1.2 ) limitations : treatment acute manic mixed episodes recommended . effectiveness lamictal acute treatment mood episodes established .",
        "doid_entities": [
            {
                "text": "lennox-gastaut syndrome (DOID:0050561)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050561"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            },
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "lennox-gastaut syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2382"
            }
        ]
    },
    "contraindications": {
        "text": "\u2022 dosing based concomitant medications , indication , patient age . ( 2.1 , 2.2 , 2.3 , 2.4 ) \u2022 avoid increased risk rash , recommended initial dose subsequent dose escalations exceeded . lamictal starter kits lamictal odt patient titration kits available first 5 weeks treatment . ( 2.1 , 16 ) \u2022 restart lamictal patients discontinued due rash unless potential benefits clearly outweigh risks . ( 2.1 , 5.1 ) \u2022 adjustments maintenance doses necessary patients starting stopping estrogen-containing products , including oral contraceptives . ( 2.1 , 5.9 ) \u2022 discontinuation : taper period least 2 weeks ( approximately 50 % dose reduction per week ) . ( 2.1 , 5.10 ) epilepsy : \u2022 adjunctive therapy\u2014see table 1 patients older 12 years tables 2 3 patients aged 2 12 years . ( 2.2 ) \u2022 conversion monotherapy\u2014see table 4 . ( 2.3 ) bipolar disorder : tables 5 6 . ( 2.4 )",
        "doid_entities": [
            {
                "text": "epilepsy (DOID:1826)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1826"
            },
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "lamictal ( lamotrigine ) tablets 25-mg , white , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 25 \u201d , bottles 100 ( ndc 0173-0633-02 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place . 100-mg , peach , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 100 \u201d , bottles 100 ( ndc 0173-0642-55 ) . 150-mg , cream , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 150 \u201d , bottles 60 ( ndc 0173-0643-60 ) . 200-mg , blue , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 200 \u201d , bottles 60 ( ndc 0173-0644-60 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place protect light . lamictal ( lamotrigine ) starter kit patients taking valproate ( blue kit ) 25-mg , white , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 25 \u201d , blister pack 35 tablets ( ndc 0173-0633-10 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place . lamictal ( lamotrigine ) starter kit patients taking carbamazepine , phenytoin , phenobarbital , primidone taking valproate ( green kit ) 25-mg , white , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 25 \u201d 100 mg , peach , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 100 \u201d , blister pack 98 tablets ( 84/25-mg tablets 14/100-mg tablets ) ( ndc 0173-0817-28 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place protect light . lamictal ( lamotrigine ) starter kit patients taking carbamazepine , phenytoin , phenobarbital , primidone , valproate ( orange kit ) 25-mg , white , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 25 \u201d 100 mg , peach , scored , shield-shaped tablets debossed \u201c lamictal \u201d \u201c 100 \u201d , blister pack 49 tablets ( 42/25-mg tablets 7/100-mg tablets ) ( ndc 0173-0594-02 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place protect light . lamictal ( lamotrigine ) tablets oral suspension 2-mg , white off-white , round tablets debossed \u201c ltg \u201d \u201c 2 \u201d , bottles 30 ( ndc 0173-0699-00 ) . order directly glaxosmithkline 1-800-334-4153 . 5-mg , white off-white , caplet-shaped tablets debossed \u201c gx cl2 \u201d , bottles 100 ( ndc 0173-0526-00 ) . 25-mg , white , super elliptical-shaped tablets debossed \u201c gx cl5 \u201d , bottles 100 ( ndc 0173-0527-00 ) . store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] dry place . lamictal odt ( lamotrigine ) orally disintegrating tablets 25-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 25 \u201d , maintenance packs 30 ( ndc 0173-0772-02 ) . 50-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 50 \u201d , maintenance packs 30 ( ndc 0173-0774-02 ) . 100-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lamictal \u201d one side \u201c 100 \u201d , maintenance packs 30 ( ndc 0173-0776-02 ) . 200-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lamictal \u201d one side \u201c 200 \u201d , maintenance packs 30 ( ndc 0173-0777-02 ) . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . lamictal odt ( lamotrigine ) patient titration kit patients taking valproate ( blue odt kit ) 25-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 25 \u201d , 50 mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 50 \u201d , blister pack 28 tablets ( 21/25-mg tablets 7/50-mg tablets ) ( ndc 0173-0779-00 ) . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . lamictal odt ( lamotrigine ) patient titration kit patients taking carbamazepine , phenytoin , phenobarbital , primidone taking valproate ( green odt kit ) 50-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 50 \u201d , 100 mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lamictal \u201d one side \u201c 100 \u201d , blister pack 56 tablets ( 42/50-mg tablets 14/100-mg tablets ) ( ndc 0173-0780-00 ) . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . lamictal odt ( lamotrigine ) patient titration kit patients taking carbamazepine , phenytoin , phenobarbital , primidone , valproate ( orange odt kit ) 25-mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 25 \u201d , 50 mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lmt \u201d one side \u201c 50 \u201d , 100 mg , white off-white , round , flat-faced , radius-edged tablets debossed \u201c lamictal \u201d one side \u201c 100 \u201d , blister pack 35 ( 14/25-mg tablets , 14/50-mg tablets , 7/100-mg tablets ) ( ndc 0173-0778-00 ) . store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) . blister packs product dispensed blister pack , patient advised examine blister pack blisters torn , broken , missing .",
    "adverseReactions": "lamictal contraindicated patients demonstrated hypersensitivity ( e.g . , rash , angioedema , acute urticaria , extensive pruritus , mucosal ulceration ) ingredients [ boxed warning , ( 5.1 , 5.3 ) ] .",
    "ingredients": [
        {
            "name": "LAMOTRIGINE",
            "code": "U3H27498KS",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6367"
        },
        {
            "name": "LACTOSE, UNSPECIFIED FORM",
            "code": "J2B2A4N98G",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "CALCIUM CARBONATE",
            "code": "H0G9379FGK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3311"
        },
        {
            "name": "LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "2165RE0K14"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32112"
        },
        {
            "name": "MAGNESIUM ALUMINUM SILICATE",
            "code": "6M3P64V0NC",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11230"
        },
        {
            "name": "CROSPOVIDONE (15 MPA.S AT 5%)",
            "code": "68401960MK"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_29864"
        },
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32159"
        },
        {
            "name": "ETHYLCELLULOSE (100 MPA.S)",
            "code": "47MLB0F1MV",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11228"
        }
    ],
    "organization": "GlaxoSmithKline LLC",
    "name": "LAMICTAL",
    "effectiveTime": "20250425",
    "indications_original": "LAMICTAL is indicated for: Epilepsy\u2014adjunctive therapy in patients aged 2 years and older: \u2022 partial-onset seizures. \u2022 primary generalized tonic-clonic (PGTC) seizures. \u2022 generalized seizures of Lennox-Gastaut syndrome. ( 1.1 ) Epilepsy\u2014monotherapy in patients aged 16 years and older: Conversion to monotherapy in patients with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug. ( 1.1 ) Bipolar disorder: Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy. ( 1.2 ) Limitations of Use: Treatment of acute manic or mixed episodes is not recommended. Effectiveness of LAMICTAL in the acute treatment of mood episodes has not been established.",
    "contraindications_original": "\u2022 Dosing is based on concomitant medications, indication, and patient age. ( 2.1 , 2.2 , 2.3 , 2.4 ) \u2022 To avoid an increased risk of rash, the recommended initial dose and subsequent dose escalations should not be exceeded. LAMICTAL Starter Kits and LAMICTAL ODT Patient Titration Kits are available for the first 5 weeks of treatment. ( 2.1 , 16 ) \u2022 Do not restart LAMICTAL in patients who discontinued due to rash unless the potential benefits clearly outweigh the risks. ( 2.1 , 5.1 ) \u2022 Adjustments to maintenance doses will be necessary in most patients starting or stopping estrogen-containing products, including oral contraceptives. ( 2.1 , 5.9 ) \u2022 Discontinuation: Taper over a period of at least 2 weeks (approximately 50% dose reduction per week). ( 2.1 , 5.10 ) Epilepsy: \u2022 Adjunctive therapy\u2014See Table 1 for patients older than 12 years and Tables 2 and 3 for patients aged 2 to 12 years. ( 2.2 ) \u2022 Conversion to monotherapy\u2014See Table 4 . ( 2.3 ) Bipolar disorder: See Tables 5 and 6 . ( 2.4 )",
    "warningsAndPrecautions_original": "LAMICTAL (lamotrigine) tablets\n                  \n                  25-mg, white, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c25\u201d, bottles of 100 (NDC 0173-0633-02).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place.\n                  100-mg, peach, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c100\u201d, bottles of 100 (NDC 0173-0642-55).\n                  150-mg, cream, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c150\u201d, bottles of 60 (NDC 0173-0643-60).\n                  200-mg, blue, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c200\u201d, bottles of 60 (NDC 0173-0644-60).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place and protect from light.\n                  \n                     LAMICTAL (lamotrigine) Starter Kit for Patients Taking Valproate (Blue Kit)\n                  \n                  25-mg, white, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c25\u201d, blister pack of 35 tablets (NDC 0173-0633-10).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place.\n                  \n                     LAMICTAL (lamotrigine) Starter Kit for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate (Green Kit)\n                  \n                  25-mg, white, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c25\u201d and 100\u00a0mg, peach, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c100\u201d, blister pack of 98 tablets (84/25-mg tablets and 14/100-mg tablets) (NDC 0173-0817-28).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place and protect from light.\n                  \n                     LAMICTAL (lamotrigine) Starter Kit for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate (Orange Kit)\n                  \n                  25-mg, white, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c25\u201d and 100\u00a0mg, peach, scored, shield-shaped tablets debossed with \u201cLAMICTAL\u201d and \u201c100\u201d, blister pack of 49 tablets (42/25-mg tablets and 7/100-mg tablets) (NDC 0173-0594-02).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place and protect from light.\n                  \n                     LAMICTAL (lamotrigine) tablets for oral suspension\n                  \n                  2-mg, white to off-white, round tablets debossed with \u201cLTG\u201d over \u201c2\u201d, bottles of 30 (NDC 0173-0699-00). ORDER DIRECTLY FROM GlaxoSmithKline 1-800-334-4153.\n                  5-mg, white to off-white, caplet-shaped tablets debossed with \u201cGX CL2\u201d, bottles of 100 (NDC 0173-0526-00).\n                  25-mg, white, super elliptical-shaped tablets debossed with \u201cGX CL5\u201d, bottles of 100 (NDC 0173-0527-00).\n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature] in a dry place.\n                  \n                     LAMICTAL ODT (lamotrigine) orally disintegrating tablets\n                  \n                  25-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c25\u201d on the other, Maintenance Packs of 30 (NDC 0173-0772-02).\n                  50-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c50\u201d on the other, Maintenance Packs of 30 (NDC 0173-0774-02).\n                  100-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLAMICTAL\u201d on one side and \u201c100\u201d on the other, Maintenance Packs of 30 (NDC 0173-0776-02).\n                  200-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLAMICTAL\u201d on one side and \u201c200\u201d on the other, Maintenance Packs of 30 (NDC 0173-0777-02).\n                  Store between 20\u00b0C and 25\u00b0C (68\u00b0F and 77\u00b0F); with excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F).\n                  \n                     LAMICTAL ODT (lamotrigine) Patient Titration Kit for Patients Taking Valproate (Blue ODT Kit)\n                  \n                  25-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c25\u201d on the other, and 50\u00a0mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c50\u201d on the other, blister pack of 28 tablets (21/25-mg tablets and 7/50-mg tablets) (NDC 0173-0779-00).\n                  Store between 20\u00b0C and 25\u00b0C (68\u00b0F and 77\u00b0F); with excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F).\n                  \n                     LAMICTAL ODT (lamotrigine) Patient Titration Kit for Patients Taking Carbamazepine, Phenytoin, Phenobarbital, or Primidone and Not Taking Valproate (Green ODT Kit)\n                  \n                  50-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c50\u201d on the other, and 100\u00a0mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLAMICTAL\u201d on one side and \u201c100\u201d on the other, blister pack of 56\u00a0tablets (42/50-mg tablets and 14/100-mg tablets) (NDC 0173-0780-00).\n                  Store between 20\u00b0C and 25\u00b0C (68\u00b0F and 77\u00b0F); with excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F).\n                  \n                     LAMICTAL ODT (lamotrigine) Patient Titration Kit for Patients Not Taking Carbamazepine, Phenytoin, Phenobarbital, Primidone, or Valproate (Orange ODT Kit)\n                  \n                  25-mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c25\u201d on the other, 50 mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLMT\u201d on one side and \u201c50\u201d on the other, and 100 mg, white to off-white, round, flat-faced, radius-edged tablets debossed with \u201cLAMICTAL\u201d on one side and \u201c100\u201d on the other, blister pack of 35 (14/25-mg tablets, 14/50-mg tablets, and 7/100-mg tablets) (NDC 0173-0778-00).\n                  Store between 20\u00b0C and 25\u00b0C (68\u00b0F and 77\u00b0F); with excursions permitted between 15\u00b0C and 30\u00b0C (59\u00b0F and 86\u00b0F).\n                  \n                     Blister Packs\n                  \n                  If the product is dispensed in a blister pack, the patient should be advised to examine the blister pack before use and not use if blisters are torn, broken, or missing.",
    "adverseReactions_original": "LAMICTAL is contraindicated in patients who have demonstrated hypersensitivity (e.g., rash, angioedema, acute urticaria, extensive pruritus, mucosal ulceration) to the drug or its ingredients [see Boxed Warning, Warnings and Precautions (5.1, 5.3)].",
    "drug": [
        {
            "name": "LAMICTAL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6367"
        }
    ]
}